Cairn Investment Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,800
| Closed | -$533K | – | 76 |
|
|
2022
Q2 | $533K | Sell |
9,800
-120
| -1% | -$6.53K | 0.41% | 52 |
|
|
2022
Q1 | $660K | Sell |
9,920
-60
| -0.6% | -$3.99K | 0.42% | 53 |
|
|
2021
Q4 | $550K | Sell |
9,980
-1,548
| -13% | -$85.3K | 0.38% | 51 |
|
|
2021
Q3 | $550K | Sell |
11,528
-64
| -0.6% | -$3.05K | 0.41% | 50 |
|
|
2021
Q2 | $576K | Sell |
11,592
-2,164
| -16% | -$108K | 0.42% | 51 |
|
|
2021
Q1 | $614K | Sell |
13,756
-1,000
| -7% | -$44.6K | 0.51% | 49 |
|
|
2020
Q4 | $679K | Sell |
14,756
-760
| -5% | -$35K | 0.64% | 46 |
|
|
2020
Q3 | $730K | Sell |
15,516
-1,680
| -10% | -$79K | 0.77% | 45 |
|
|
2020
Q2 | $876K | Sell |
17,196
-416
| -2% | -$21.2K | 1.06% | 42 |
|
|
2020
Q1 | $834K | Sell |
17,612
-1,280
| -7% | -$60.6K | 1.24% | 34 |
|
|
2019
Q4 | $1.11M | Buy |
+18,892
| New | +$1.11M | 1.1% | 39 |
|